Ratings by Oppenheimer (Andreas Argyrudes)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/30/2025 | Regulus Therapeutics | RGLS | Downgrade | Perform (Outperform) |
3.37 (8.16) |
142.14% | Details | |
| 8/2/2024 | Regulus Therapeutics | RGLS | New Coverage | Outperform (N/A) |
1.80 (8.16) |
353.33% | Details |
